4D Molecular Therapeutics (FDMT) Book Value

Price: $3.34
Market Cap: $154.65M
Avg Volume: 827.34K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 2.876
52W Range: $2.235-28.927
Website: 4D Molecular Therapeutics

What is 4D Molecular Therapeutics's Book Value?

  • 4D Molecular Therapeutics's annual Book Value is $510.61M.
  • 4D Molecular Therapeutics's quarterly Book Value is $510.61M.

What is Book Value?

Book Value represents the total value of a company's assets that shareholders would theoretically receive if a company were liquidated. It is calculated as the total assets minus intangible assets and total liabilities.

How is Book Value calculated?

Book Value is calculated using the following formula:

Book Value = Total Assets - Intangible Assets - Total Liabilities

Related Metrics

Other important metrics to assess 4D Molecular Therapeutics's financial health include:

  • Book Value per Share - measures the per-share value of a company based on its equity:
    • Annual: $9.47
    • Quarterly: $9.47
  • Tangible Book Value per Share - measures the per-share value of a company's tangible assets:
    • Annual: $9.47
    • Quarterly: $9.47

These metrics provide insights into 4D Molecular Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Book Value

$510.61M

Quarterly Book Value

$510.61M

4D Molecular Therapeutics Historical Book Value
$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.00-$200.00M-$200.00M-$400.00M-$400.00MBook Value2018201820192019202020202021202120222022202320232024202420252025
Historical Book Value per Share
$12.00$12.00$8.00$8.00$4.00$4.00$0.00$0.00$-4.00$-4.00$-8.00$-8.00Book Value per Share2018201820192019202020202021202120222022202320232024202420252025
Historical Tangible Book Value per Share
$12.00$12.00$8.00$8.00$4.00$4.00$0.00$0.00$-4.00$-4.00$-8.00$-8.00Tangible Book Value per Share2018201820192019202020202021202120222022202320232024202420252025

4D Molecular Therapeutics Historical Financial Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Book Value Book Value Change Book Value per Share Tangible Book Value per Share
2024 $510.61M 65.87% 9.47 9.47
2023 $307.83M -197.88% 7.87 7.87
2022 $-314.49M 51.93% 7.15 7.15
2021 $-207.00M -180.74% -7.46 -7.46
2020 $256.39M -451.36% 9.61 9.61
2019 $-72.97M 164.51% -2.75 -2.75
2018 $-27.59M 40.82% -2.20 -2.20
2017 $-19.59M N/A -1.32 -1.32

Related Metrics

Explore detailed financial metrics and analysis for FDMT.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio